As of 2025-05-16, the EV/EBITDA ratio of Aveo Pharmaceuticals Inc (AVEO) is -19.76. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVEO's latest enterprise value is 482.73 mil USD. AVEO's TTM EBITDA according to its financial statements is -24.43 mil USD. Dividing these 2 quantities gives us the above AVEO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 13.3x | 13.1x |
| Forward P/E multiples | 16.5x - 30.7x | 19.0x |
| Fair Price | (10.47) - (8.20) | (10.16) |
| Upside | -169.8% - -154.7% | -167.8% |
| Date | EV/EBITDA |